Genomtec SA
WSE:GMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Genomtec SA (GMT) under the Base Case is PLN per share. Compared with the current market price of 2.5 PLN, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Genomtec Does
Genomtec is a Polish life-science company that develops molecular diagnostics tools for detecting genetic material from pathogens and other biological samples. Its core work centers on laboratory and point-of-care testing systems, including the test cartridges and instruments needed to run them. The company sells its technology into healthcare and diagnostics, where fast and accurate identification of infections matters.
- Headquarters
- Poland PL
- IPO date
- Mar 17, 2021
Balance Sheet
Continue GMT Research
Decided on Genomtec? Get an email when GMT reaches the price you’d buy at. Free with an account.
Other Genomtec listings
What is the Intrinsic Value of one GMT stock?
The intrinsic value for Genomtec SA (GMT) under the Base Case is PLN.
Is GMT stock undervalued or overvalued?
Compared with the current market price of 2.5 PLN, the stock appears .